125 related articles for article (PubMed ID: 37813500)
1. The impact of syringe decriminalization within the Pennsylvania harm reduction community.
Lepore M; Hessler J; Mitchell A; Kameg B; Howe R; Cassidy C; Germack H
Arch Psychiatr Nurs; 2023 Oct; 46():26-32. PubMed ID: 37813500
[TBL] [Abstract][Full Text] [Related]
2. Syringe Decriminalization Advocacy in Red States: Lessons from the North Carolina Harm Reduction Coalition.
Cloud DH; Castillo T; Brinkley-Rubinstein L; Dubey M; Childs R
Curr HIV/AIDS Rep; 2018 Jun; 15(3):276-282. PubMed ID: 29740734
[TBL] [Abstract][Full Text] [Related]
3. Peer-delivered harm reduction and recovery support services: initial evaluation from a hybrid recovery community drop-in center and syringe exchange program.
Ashford RD; Curtis B; Brown AM
Harm Reduct J; 2018 Oct; 15(1):52. PubMed ID: 30348170
[TBL] [Abstract][Full Text] [Related]
4. The value of harm reduction for injection drug use: A clinical and public health ethics analysis.
Vearrier L
Dis Mon; 2019 May; 65(5):119-141. PubMed ID: 30600096
[TBL] [Abstract][Full Text] [Related]
5. Attitudes of North Carolina law enforcement officers toward syringe decriminalization.
Davis CS; Johnston J; de Saxe Zerden L; Clark K; Castillo T; Childs R
Drug Alcohol Depend; 2014 Nov; 144():265-9. PubMed ID: 25193720
[TBL] [Abstract][Full Text] [Related]
6. Attitudes toward syringe exchange programs in a rural Appalachian community.
Zeller TA; Beachler T; Diaz L; Thomas RP; Heo M; Lanzillotta-Rangeley J; Litwin AH
J Addict Dis; 2022; 40(2):227-234. PubMed ID: 34550054
[TBL] [Abstract][Full Text] [Related]
7. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
Emmanuelli J; Desenclos JC
Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
[TBL] [Abstract][Full Text] [Related]
8. [Community collection of syringes by parenteral drug users complementary to syringe exchange programs].
Bechich S; Martínez M; Llorella G; Rodés A; De Andrés M; Delás J
Gac Sanit; 2001; 15(4):353-5. PubMed ID: 11578566
[TBL] [Abstract][Full Text] [Related]
9. Co-design of harm reduction materials for people who inject drugs to implement research findings.
Hussey D; Trinder-Widdess Z; Dee C; Bagnall D; Bojangles T; Kesten JM
Harm Reduct J; 2019 Jun; 16(1):36. PubMed ID: 31174536
[TBL] [Abstract][Full Text] [Related]
10. "We're actually more of a likely ally than an unlikely ally": relationships between syringe services programs and law enforcement.
Franco CY; Lee-Winn AE; Brandspigel S; Alishahi ML; Brooks-Russell A
Harm Reduct J; 2021 Aug; 18(1):81. PubMed ID: 34348714
[TBL] [Abstract][Full Text] [Related]
11. The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.
Ude M; Behrends CN; Kelly S; Schackman BR; Clear A; Goldberg R; Gelberg K; Kapadia SN
Harm Reduct J; 2023 Feb; 20(1):12. PubMed ID: 36732773
[TBL] [Abstract][Full Text] [Related]
12. Estimating the number of people who inject drugs and syringe coverage in Australia, 2005-2016.
Kwon JA; Iversen J; Law M; Dolan K; Wand H; Maher L
Drug Alcohol Depend; 2019 Apr; 197():108-114. PubMed ID: 30802734
[TBL] [Abstract][Full Text] [Related]
13. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
[TBL] [Abstract][Full Text] [Related]
14. Community attitudes towards harm reduction services and a newly established needle and syringe automatic dispensing machine in an inner-city area of Sydney, Australia.
White B; Haber PS; Day CA
Int J Drug Policy; 2016 Jan; 27():121-6. PubMed ID: 26118798
[TBL] [Abstract][Full Text] [Related]
15. Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia.
Otiashvili D; Kirtadze I; Vardanashvili I; Tabatadze M; Ober AJ
Harm Reduct J; 2019 Mar; 16(1):21. PubMed ID: 30898120
[TBL] [Abstract][Full Text] [Related]
16. Syringe access and health harms: Characterizing "landscapes of antagonism" in California's Central Valley.
Syvertsen JL; Pollini RA
Int J Drug Policy; 2020 Jan; 75():102594. PubMed ID: 31775079
[TBL] [Abstract][Full Text] [Related]
17. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
[TBL] [Abstract][Full Text] [Related]
18. Shifting the paradigm: physician-authorized, student-led efforts to provide harm reduction services amidst legislative opposition.
McMullen TP; Naeim M; Newark C; Oliphant H; Suchard J; Banimahd F
Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):27. PubMed ID: 33761954
[TBL] [Abstract][Full Text] [Related]
19. Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia.
O'Keefe D; Livingston M; Cossar RD; Kerr P; Jacka D; Dietze P
Harm Reduct J; 2022 Sep; 19(1):101. PubMed ID: 36071500
[TBL] [Abstract][Full Text] [Related]
20. Harm Reduction Coverage and Hepatitis C Incidence: Findings From a Cohort of People Who Inject Drugs.
Minoyan N; Artenie AA; Zang G; Jutras-Aswad D; Turcotte MÈ; Bruneau J
Am J Prev Med; 2020 Jun; 58(6):845-853. PubMed ID: 32444003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
